The greatest achievements are not reached on your own: they are the result of teamwork and combination of skills !

To remain competitive in the global marketplace, leading companies must develop a constant stream of innovative products.

Since its foundation in 1999, IPSOGEN has grown to become one of Europe’s leading independent oncology molecular diagnostic companies. This growth and this success are in a large part based on external discoveries, successfully brought to the market by IPSOGEN in a close partnership with their originators.

Now, with more than 80 tests already used routinely worldwide for the diagnosis, prognosis and follow-up of thousands of patients with leukemia, IPSOGEN is now also targeting other cancers with the aim of providing currently inaccessible diagnostic information.

Strengthened by its scientific, clinical and technological partnerships, and by its multidisciplinary team in France and the USA, IPSOGEN intends to become a world leader in the molecular profiling of cancers … and that could be done with you!

So, if you've discovered something significant, perhaps it’s time to work together to turn your discovery's potential into a patient bedside tool… and into a commercial success!

Partnerships frameworks

Our partnerships have always been built on a case-by-case basis for a win-win relationship and for the long term. It can be licensing, collaborative researches, collaborative clinical trials, commercial partnerships: we bring flexibility in our partnerships, and build it together with you.